Royal Queen Seeds Releases Firsthand Accounts of New F1 Hybrid Seeds
International seed bank Royal Queen Seeds recently shared feedback from the first growers of their new F1 hybrid seeds.
After debuting their new F1 hybrid seeds earlier this year (1), international seed bank Royal Queen Seeds (RQS) shared results from releasing these seeds to homegrowers.
“Many cannabis seed companies market their seeds as F1 hybrids,” RQS said in a recent statement (2). “In the world of breeding, the term ‘F1’ simply describes the plants that make up the first generation following a cross. However, the majority of modern cannabis strains are created using unstable parents. This means they display inferior uniformity and lack the vigour of true F1 hybrids.”
According to RQS, the first wave of growers of their new hybrid seeds noted the speed of the plants’ maturation, size, and predictability of shape, among other aspects (2). “Impressive potency and high resin production,” stated one review that RQS highlighted (2). “Hard and full with a wonderful smell,” was part of another highlighted review (2).
RQS stated that the new F1 hybrid plants will produce more tetrahydrocannabinol (THC) and terpenes and will also be less prone to disease (2).
References
- McEvoy, E. Royal Queen Seeds presented new F1 hybrids to industry https://www.cannabissciencetech.com/view/royal-queen-seeds-presented-new-f1-hybrids-to-industry (accessed Jun 23, 2023).
- Royal Queen seeds USA https://www.royalqueenseeds.com/us/ (accessed Jun 23, 2023).
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
